465 related articles for article (PubMed ID: 37111579)
1. Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems.
Wu KY; Joly-Chevrier M; Akbar D; Tran SD
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111579
[TBL] [Abstract][Full Text] [Related]
2. Breaking Barriers in Eye Treatment: Polymeric Nano-Based Drug-Delivery System for Anterior Segment Diseases and Glaucoma.
Wu KY; Ashkar S; Jain S; Marchand M; Tran SD
Polymers (Basel); 2023 Mar; 15(6):. PubMed ID: 36987154
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
[TBL] [Abstract][Full Text] [Related]
4. Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan.
Burhan AM; Klahan B; Cummins W; Andrés-Guerrero V; Byrne ME; O'Reilly NJ; Chauhan A; Fitzhenry L; Hughes H
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683978
[TBL] [Abstract][Full Text] [Related]
5. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
6. Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery.
Lynch C; Kondiah PPD; Choonara YE; du Toit LC; Ally N; Pillay V
Polymers (Basel); 2019 Aug; 11(8):. PubMed ID: 31434273
[TBL] [Abstract][Full Text] [Related]
7. Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.
Bisht R; Mandal A; Jaiswal JK; Rupenthal ID
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28425224
[TBL] [Abstract][Full Text] [Related]
8. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
9. Lipid-Based Nanocarriers as Topical Drug Delivery Systems for Intraocular Diseases.
Navarro-Partida J; Castro-Castaneda CR; Santa Cruz-Pavlovich FJ; Aceves-Franco LA; Guy TO; Santos A
Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065059
[TBL] [Abstract][Full Text] [Related]
10. A New Era in Ocular Therapeutics: Advanced Drug Delivery Systems for Uveitis and Neuro-Ophthalmologic Conditions.
Wu KY; Tan K; Akbar D; Choulakian MY; Tran SD
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514137
[TBL] [Abstract][Full Text] [Related]
11. Nano-based ocular drug delivery systems: an insight into the preclinical/clinical studies and their potential in the treatment of posterior ocular diseases.
Su Y; Fan X; Pang Y
Biomater Sci; 2023 Jun; 11(13):4490-4507. PubMed ID: 37222479
[TBL] [Abstract][Full Text] [Related]
12. Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.
Ponzini E; Astolfi G; Grandori R; Tavazzi S; Versura P
Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931931
[TBL] [Abstract][Full Text] [Related]
13. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
14. Potential in exosome-based targeted nano-drugs and delivery vehicles for posterior ocular disease treatment: from barriers to therapeutic application.
Peng X; Zhang T; Liu R; Jin X
Mol Cell Biochem; 2024 Jun; 479(6):1319-1333. PubMed ID: 37402019
[TBL] [Abstract][Full Text] [Related]
15. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
Wu KY; Wang XC; Anderson M; Tran SD
Molecules; 2024 May; 29(10):. PubMed ID: 38792122
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
Bisht R; Jaiswal JK; Rupenthal ID
Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
[TBL] [Abstract][Full Text] [Related]
17. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
18. A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.
Choonara YE; Pillay V; Danckwerts MP; Carmichael TR; du Toit LC
J Pharm Sci; 2010 May; 99(5):2219-39. PubMed ID: 19894268
[TBL] [Abstract][Full Text] [Related]
19. Ocular Drug Delivery: Present Innovations and Future Challenges.
Gote V; Sikder S; Sicotte J; Pal D
J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable Microspheres as Intravitreal Delivery Systems for Prolonged Drug Release. What is their Eminence in the Nanoparticle Era?
Gavini E; Bonferoni MC; Rassu G; Obinu A; Ferrari F; Giunchedi P
Curr Drug Deliv; 2018; 15(7):930-940. PubMed ID: 29484995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
